Krishna Vaddi, CEO: Prelude Therapeutics PRLD Buy · Filed 25/01/03

Trade details

Type: Insider buy
Amount: $6,050
Shares · price: 5,000 sh · $1.21 a share
Held after: 142,553 sh
Stock: Prelude Therapeutics PRLD
Person: Krishna VaddiCEO
Trade date: 24/12/31
Filed: 25/01/03
Days to filing: 3 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +3.6%

Prelude Therapeutics trades, last 26 weeks

What else happened in Prelude Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/01~25/01/30

Krishna Vaddi's recent trades

Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$465.8K
675,000 sh
$465.8K
Filed 25/03/27
Traded 25/03/25
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$11K
15,000 sh
$11K
Filed 25/03/24
Traded 25/03/21
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$3,954
5,416 sh
$3,954
Filed 25/03/24
Traded 25/03/20
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$22.5K
29,999 sh
$22.5K
Filed 25/03/18
Traded 25/03/14
Krishna VaddiCEO
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$6,830
9,106 sh
$6,830
Filed 25/03/18
Traded 25/03/17